IF image of human rectum carcinoma tissue using TAG72 antibody (primary antibody at 5 ug/ml)|Immunofluorescence analysis of human rectum carcinoma tissue using TAG72 antibody (dilution of primary antibody - 5 ug/ml)|IF analysis of human rectum carcinoma tissue using anti-TAG72 (dilution of primary antibody at 5 ug/ml)|Immunofluorescence image of human rectum carcinoma tissue using TAG72 antibody (dilution at 5 ug/ml)|Immunohistochemical staining of human thyroid cancer tissue using anti-TAG72 (dilution of primary antibody - 5 ug/ml)|Immunohistochemical staining of paraffin embedded human rectum carcinoma tissue using TAG72 antibody (primary antibody at 5 ug/ml)|IHC-P image of human rectum carcinoma tissue using TAG72 antibody (dilution of primary antibody at 5 ug/ml)|IHC-P staining of human ovary cancer tissue using TAG72 antibody (dilution at 5 ug/ml)|IHC-P image of human ovary cancer tissue using TAG72 antibody (dilution of primary antibody at 5 ug/ml)|Immunohistochemical staining of paraffin embedded human breast cancer tissue using anti-TAG72 (primary antibody at 5 ug/ml)|Western blot analysis of human lung cancer (lane 1), human breast cancer (lane 2), human thyroid cancer (lane 3), U251 cells (lane 4); Hels cells (lane 5) using TAG72 antibody (1 ug/ml)
Supplier Page from Biorbyt for TAG-72 antibody
Application Notes: A In-111-labeled, murine version of this antibody was used in immunoscintigraphy to detect colorectal cancers in patients. In 16 % of patients, human-anti-mouse-responses developed.